Mark Miceli, DPM
Primary Podiatric Medicine · Gastonia, NCNPI 1881678118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for primary podiatric medicine clinicians in NC, where the typical reported total is $1,305.
Across 30 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$69
- Smith+Nephew$65
- AbbVie$37
- Johnson & Johnson$37
- Triad Life Sciences Inc.$28
- Nevro Corp.$27
- plus $321 from 17 others
What the payments were for
- Food & beverage$584100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 3 | $69 |
| Smith+Nephew | 4 | $65 |
| AbbVie | 2 | $37 |
| Johnson & Johnson | 1 | $37 |
| Triad Life Sciences Inc. | 1 | $28 |
| Nevro Corp. | 1 | $27 |
| Melinta Therapeutics, LLC | 1 | $27 |
| Progenacare Global, LLC | 1 | $26 |
| Abbott | 1 | $26 |
| Vertex | 1 | $24 |
| Biowound Solutions, Inc. | 2 | $23 |
| GRT US Holding, Inc. | 1 | $22 |
| Zimmer Biomet | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Mimedx Group, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
| Stryker | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
| Novum Pharma, LLC | 1 | $13 |
| Hartmann USA, Inc. | 1 | $12 |
How this compares
$584 in reported general payments places this provider in the 25th percentile of 64 primary podiatric medicine providers in North Carolina.
See all primary podiatric medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 34 | $758 |
| Diclofenac Sodium | 24 | $654 |
| Ketoconazole | 40 | $595 |
| Ammonium Lactate | 21 | $552 |
| Gabapentin | 56 | $516 |
| Lidocaine | 18 | $508 |
| Doxycycline Hyclate | 35 | $267 |
| Cephalexin | 47 | $206 |
| Silver Sulfadiazine | 20 | $145 |
| Celecoxib | 11 | $110 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $83 |
| Methylprednisolone | 11 | $71 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $48 |
| Tramadol Hcl | 22 | $42 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Gastonia
- Randall ContentoGastonia$4K
- Colin MoffettGastonia$215
- Ashma DavidsonStatesville$32K
- Joseph KiblerSupply$23K
- Jacob PaniciCary$13K
- Ythan WebsterNew Bern$10K
- Jon StancilGreenville$9K
- Kevin McDonaldConcord$8K
- Eric WardMatthews$7K
- Clark BrackneyGreensboro$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.